Oncolytics Biotech
Presence
Oncolytics Biotech is a company listed under the stock ticker ONC (CA).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at Oncolytics Biotech
- Matthew Coffey, Director, President and Chief Executive Officer
- Bernd Seizinger, Director
- Wayne Pisano, Chairman of the Board
Popular executive movements at Oncolytics Biotech
- Patricia Andrews has joined the company as Director (posted on January 9 2024).
- Patricia Andrews has joined the company as Director (posted on January 9 2024).
Create your alert
to follow the executive moves at Oncolytics Biotech.
Biotechnology
Oncolytics Biotech has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Oncolytics Biotech
- Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA | Oncolytics Biotech Inc.
- Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference | Oncolytics Biotech Inc.
- Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights | Oncolytics Biotech Inc.
- Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference | Oncolytics Biotech Inc.
- Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights | Oncolytics Biotech Inc.
- Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN | Oncolytics Biotech Inc.
- Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort | Oncolytics Biotech Inc.
- Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors | Oncolytics Biotech Inc.
- Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024 | Oncolytics Biotech Inc.
- Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS | Oncolytics Biotech Inc.
- View more press releases Close
Social media about Oncolytics Biotech
- Oncolytics Biotech on Wikipedia, Google News & Yahoo Finance
- Oncolytics Biotech on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Wayne Pisano 
Call Oncolytics Biotech at +1 403...
